Journal Articles and White Papers
Frequently Asked Questions
Cardiovascular Disease Videos
Siemens Healthineers is pleased to offer a series of educational videos focusing on the clinical utility of high-sensitivity troponin I. Hear leaders in the area of cardiovascular disease and laboratory diagnostics discuss the importance of implementing a high-sensitivity troponin I assay into their facility.
Cardiovascular Disease Webinars
AACC Sponsored Webinar: Laboratory and Clinical Perspectives
Understanding Findings of Sex-specific 99th Percentile URLs for High-sensitivity Cardiac Troponin Assays Derived from Universal Sample Bank
Selection of healthy reference populations and definition of exclusion criteria for deriving 99th percentiles for high-sensitivity cardiac troponin assays used in clinical practice and research vary considerably in the literature. We discuss the Universal Sample Bank findings regarding their clinical implications:
a) Sex-specific 99th percentiles varied according to the statistical method and hs-cTn assay used.
b) Not all assays provided measurable concentrations for women to qualify as hs assays.
c) Surrogate exclusion criteria used to define normality tended to lower 99th percentiles. Participants will learn that the decision concentrations used can affect diagnostics, risk-outcome assessments, and analytical characteristics.
Implementation of a High-Sensitivity Troponin I Assay
AACC Thought Leadership Webinar Series
The Fourth Universal Definition of Myocardial Infarction recommends high-sensitivity troponin assays for routine clinical use. Compared to standard (guideline-acceptable) cardiac troponin assays, high-sensitivity assays offer improved sensitivity and unparalleled precision at the low end of the measuring range. With the availability of high-sensitivity troponin I assays in the U.S., more laboratories have the ability to implement high-sensitivity troponin I.
Join Dr. Allan Jaffe to learn about the latest recommendations and communication needed with your key clinical partners when transitioning to a high-sensitivity troponin assay.